I Workshop of the NyNA Consortium – Young Researchers in Nanoscience and Analytical Nanotechnologies
ICN2 took part in the I Workshop of the NyNA Consortium – Young Researchers in Nanoscience and Analytical...
Read more
Supple Graphene Bio-Platform for point-of-care early detection and monitoring of Alzheimer’s Disease.
Learn moreIn a Nutshell
2D-BioPAD is pioneering a graphene-based Point-of-Care (PoC) In-Vitro Diagnostics (IVD) system for early Alzheimer’s Disease (AD) detection. This non-invasive solution, using 2D materials, can identify and quantify up to 5 AD biomarkers in real-time. Clinical pilot studies in Finland, Greece, and Germany aim to demonstrate its impact, with a focus on safety, ethics, and seamless integration into primary healthcare settings.
Latest News
Discover our clinical centres – Meet Alzheimer Hellas
Tell us a few words about your organisation… Alzheimer Hellas is a non-profit organization based in Greece dedicated...
Read more
2D-BioPAD at the 35th Anniversary World Congress on Biosensors
2D-BioPAD had a strong presence at the 35th Anniversary World Congress on Biosensors, held in Lisbon from May...
Read more
Discover our clinical centres – Meet UEF
Tell us a few words about your organisation… The Brain Research Unit (BRU) at the University of Eastern...
Read more
Consortium Partners
